Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations
View →
Q1
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
Q1
RICCHETTI INCORPORATED for IPSEN BIOPHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy, Medicare/Medicaid
View →
RR
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland
Veterans, Alcohol and Drug Abuse, Budget/Appropriations, Health Issues
View →
1T
RICCHETTI INCORPORATED for EISAI, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
HEALTHSPERIEN for EXACT CARE PHARMACY
1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · Senate
Pharmacy, Health Issues
View →
Q1
FAEGRE DRINKER BIDDLE & REATH LLP for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $30,000.00 income
Health Issues, Pharmacy
View →
Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
1A
ICE MILLER LLP for COALITION FOR RESPONSIBLE COMPOUDING INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · $10,000.00 income
Pharmacy
View →
Q1
BOLD STRATEGIES, LLC for MORRIS & DICKSON CO., LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Louisiana · House · Senate · $10,000.00 income
Health Issues, Pharmacy
View →
Q1
TAUZIN STRATEGIC NETWORKS for RAZORMETRICS
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $37,500.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
PENN AVENUE PARTNERS for ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
FORBES-TATE for INDEPENDENT PHARMACY COOPERATIVE
1st Quarter (Jan 1 - Mar 31) 2025 · Wisconsin · House · Senate · $30,000.00 income
Health Issues, Pharmacy, Medicare/Medicaid
View →
Q1
FORBES-TATE for PHRMA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Consumer Issues/Safety/Products
View →
Q1
ICE MILLER LLP for COALITION FOR RESPONSIBLE COMPOUDING INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $10,000.00 income
Pharmacy
View →
Q1
THE ROTUNDA GROUP LLC for HEALTHPLAN DATA SOLUTIONS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · $10,000.00 income
Pharmacy
View →
Q1
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $201,227.00 income
Health Issues, Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q1
POLSINELLI PC for RESQ PHARMA
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · $10,000.00 income
Pharmacy
View →
Q1
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CHILDREN'S NATIONAL MEDICAL CENTER
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
RR
ARENTFOX SCHIFF LLP for PHARVARIS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts
Health Issues, Medicare/Medicaid, Pharmacy, Trade (domestic/foreign)
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CVS HEALTH
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid, Insurance
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Pharmacy, Defense, Taxation/Internal Revenue Code
View →
Previous Page 69 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem